angiotensin ii, des-phe(8)- has been researched along with egtazic acid in 1 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (egtazic acid) | Trials (egtazic acid) | Recent Studies (post-2010) (egtazic acid) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 10,021 | 11 | 686 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castelo-Branco, RC; de Mello-Aires, M; Leite-Delova, DC | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and egtazic acid
| Article | Year |
|---|---|
Dose-dependent effects of angiotensin-(1-7) on the NHE3 exchanger and [Ca(2+)](i) in in vivo proximal tubules.
Topics: Angiotensin I; Animals; Bicarbonates; Calcium; Dose-Response Relationship, Drug; Egtazic Acid; Guanidines; Kidney Tubules, Proximal; Male; Methacrylates; Peptide Fragments; Rats; Rats, Wistar; Signal Transduction; Sodium-Hydrogen Exchangers; Thapsigargin | 2013 |